Although considerable progress has been made in delaying the onset of CKD through inhibition of the renin–angiotensin system in a significant proportion of patients, the search for new therapeutic approaches to prevent or halt CKD progression remains a healthcare priority. The gene discussed is REN; the disease is chronic kidney disease.